Executive Board The CGHE Executive Board is charged with providing strategic leadership and governance oversight. We are grateful for the contributions and guidance provided by the following leaders. Attachments pdf 421.96 KB Executive Board Charges and Terms of Reference Dr. Harvey J. Alter Nobel Laureate, Medicine & Physiology, 2020 Dr. Maria Buti University Hospital Vall d'Hebron Dr. Stephanie Campbell Senior Regional Medical Director, Medical Affairs, Dynavax Technologies Dr. Gavin Cloherty Head of Infectious Disease Research, Abbott Dr. Charles (Chuck) Cooper Chief Medical Officer, Diagnostics, Siemens Healthineers Matthew D'Uva Chief Executive Officer, American Association for the Study of Liver Diseases (AASLD) Dr. Samir Desai President & Head of BU Biologics, Zydus Lifesciences Dr. Amr Fahmy Corporate Director - Egypt, Pharco Pharmaceuticals Julia Gin Director of Global Citizenship & Vice President of Abbott Fund Tanzania, Abbott Tommy Good Senior International Product Manager for Hepatitis, Roche Molecular Diagnostic Rachel Halford President, The World Hepatitis Alliance Dr. Sherine Hassan Abbas Helmy Chief Executive Officer, Pharco Pharmaceuticals Cary James Chief Executive Officer, The World Hepatitis Alliance Dr. Robert Janssen Chief Medical Officer & Senior Vice President, Clinical Development, Dynavax Technologies Patrick Knobel Director, Therapeutic Area Strategies – Specialty Care (Neuroscience, Eye Care and Virology) International Government Affairs, AbbVie Dr. Bruce Kreter Executive Director, Global HCV Medical Affairs, Gilead Sciences Dr. Benjamin LaBrot Global Medical Affairs Lead for Infection & Immunity, Roche Molecular Diagnostic Professor George Lau Chairman, Humanity and Health Medical Center, Hong Kong SAR and Chair Professor and Director, 302 Beijing - Humanity and Health Hepatitis C Clinic, Beijing Dr. Lillian Lou President & Program Director, The John C. Martin Foundation Paul Schaper Associate Vice President, Global Pharmaceutical Public Policy, Merck Dr. Raymond Schinazi Professor Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine Dr. Marcelo Silva President, Latin American Association for the Study of Liver Diseases Dr. Carolyn Wester Director of the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. CDC Page last updated: 11 March 2024
Dr. Robert Janssen Chief Medical Officer & Senior Vice President, Clinical Development, Dynavax Technologies
Patrick Knobel Director, Therapeutic Area Strategies – Specialty Care (Neuroscience, Eye Care and Virology) International Government Affairs, AbbVie
Professor George Lau Chairman, Humanity and Health Medical Center, Hong Kong SAR and Chair Professor and Director, 302 Beijing - Humanity and Health Hepatitis C Clinic, Beijing
Dr. Raymond Schinazi Professor Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine
Dr. Carolyn Wester Director of the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. CDC